Pharmacological activation of constitutive androstane receptor induces female-specific modulation of hepatic metabolism.

Hepatic xenobiotic metabolism Lipoprotein metabolism Platelet aggregation Sexual dimorphism Trimethylamine-N-oxide

Journal

JHEP reports : innovation in hepatology
ISSN: 2589-5559
Titre abrégé: JHEP Rep
Pays: Netherlands
ID NLM: 101761237

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 17 04 2023
revised: 25 09 2023
accepted: 27 09 2023
medline: 27 12 2023
pubmed: 27 12 2023
entrez: 27 12 2023
Statut: epublish

Résumé

The constitutive androstane receptor (CAR) is a nuclear receptor that binds diverse xenobiotics and whose activation leads to the modulation of the expression of target genes involved in xenobiotic detoxification and energy metabolism. Although CAR hepatic activity is considered to be higher in women than in men, its sex-dependent response to an acute pharmacological activation has seldom been investigated. The hepatic transcriptome, plasma markers, and hepatic metabolome, were analysed in Although 90% of TCPOBOP-sensitive genes were modulated in a sex-independent manner, the remaining 10% showed almost exclusive female liver specificity. These female-specific More than 10% of CAR-sensitive genes are sex-specific and influence hepatic and systemic responses such as platelet aggregation. CAR activation may be an important mechanism of sexually-dimorphic drug-induced liver injury. CAR is activated by many drugs and pollutants. Its pharmacological activation had a stronger impact on hepatic gene expression and metabolism in females than in males, and had a specific impact on liver toxicity and trimethylamine metabolism. Sexual dimorphism should be considered when testing and/or prescribing xenobiotics known to activate CAR.

Sections du résumé

Background & Aims UNASSIGNED
The constitutive androstane receptor (CAR) is a nuclear receptor that binds diverse xenobiotics and whose activation leads to the modulation of the expression of target genes involved in xenobiotic detoxification and energy metabolism. Although CAR hepatic activity is considered to be higher in women than in men, its sex-dependent response to an acute pharmacological activation has seldom been investigated.
Methods UNASSIGNED
The hepatic transcriptome, plasma markers, and hepatic metabolome, were analysed in
Results UNASSIGNED
Although 90% of TCPOBOP-sensitive genes were modulated in a sex-independent manner, the remaining 10% showed almost exclusive female liver specificity. These female-specific
Conclusions UNASSIGNED
More than 10% of CAR-sensitive genes are sex-specific and influence hepatic and systemic responses such as platelet aggregation. CAR activation may be an important mechanism of sexually-dimorphic drug-induced liver injury.
Impact and implications UNASSIGNED
CAR is activated by many drugs and pollutants. Its pharmacological activation had a stronger impact on hepatic gene expression and metabolism in females than in males, and had a specific impact on liver toxicity and trimethylamine metabolism. Sexual dimorphism should be considered when testing and/or prescribing xenobiotics known to activate CAR.

Identifiants

pubmed: 38149074
doi: 10.1016/j.jhepr.2023.100930
pii: S2589-5559(23)00261-6
pmc: PMC10749885
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100930

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest. Please refer to the accompanying ICMJE disclosure forms for further details.

Auteurs

Marine Huillet (M)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Frédéric Lasserre (F)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Marie-Pierre Gratacap (MP)

INSERM, UMR-1297 and Université Toulouse III, Institut de Maladies Métaboliques et Cardiovasculaires (I2MC), CHU-Rangueil, Toulouse, France.

Beatrice Engelmann (B)

Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research, Leipzig, Germany.

Justine Bruse (J)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Arnaud Polizzi (A)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Tiffany Fougeray (T)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Céline Marie Pauline Martin (CMP)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Clémence Rives (C)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Anne Fougerat (A)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Claire Naylies (C)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Yannick Lippi (Y)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Géraldine Garcia (G)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Elodie Rousseau-Bacquie (E)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Cécile Canlet (C)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Laurent Debrauwer (L)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Ulrike Rolle-Kampczyk (U)

Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research, Leipzig, Germany.

Martin von Bergen (M)

Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research, Leipzig, Germany.

Bernard Payrastre (B)

INSERM, UMR-1297 and Université Toulouse III, Institut de Maladies Métaboliques et Cardiovasculaires (I2MC), CHU-Rangueil, Toulouse, France.
Laboratoire d'Hématologie, CHU de Toulouse, Toulouse, France.

Elisa Boutet-Robinet (E)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Laurence Gamet-Payrastre (L)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Hervé Guillou (H)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Nicolas Loiseau (N)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Sandrine Ellero-Simatos (S)

Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.

Classifications MeSH